Login to Your Account



Autolus raises $80M to push ahead in CAR T race

By Cormac Sheridan
Staff Writer

Tuesday, September 26, 2017

DUBLIN – Autolus Ltd. closed an $80 million series C round, the largest private equity deal in European biotech this year, to progress its clinical pipeline of autologous CAR T-cell therapies in hematological malignancies.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription